Literature DB >> 19512910

Fusarium keratitis in Mexico.

Ana Lilia Pérez-Balbuena1, Virginia Vanzzini-Rosano, José de Jesús Valadéz-Virgen, Xavier Campos-Möller.   

Abstract

PURPOSE: To describe the clinical characteristics, diagnosis, treatment, and visual outcome of 61 cases of Fusarium keratitis in Mexico.
METHODS: Retrospective, comparative study of 61 patients with clinically and culture-confirmed Fusarium keratitis, who were attended at an eye hospital in Mexico City from 1981 to 2001.
RESULTS: Fusarium solani was the main causal agent in 83.6% of cases. Trauma history was observed in 57.4% and a history of agricultural activity in 34.4%. Signs were redness (100%), epithelial defects (98.3%), superficial corneal ulcer (95.1%), anterior chamber inflammation (91.8%), and satellite infiltrates (75.4%). In 50% of cases, the treatment was topical ketoconazole 2%; in 34.2% of cases, additional topical antifungal preparations were used. A total of 77% of patients improved and 23% worsened. Conjunctival flap was indicated in 4 of 61 patients (6.5%), and 14 of 61 patients (23%) underwent penetrating keratoplasty. Two of 61 patients were treated with tectonic keratoplasty. Evisceration surgeries were practiced in 14 of 61 patients (22.9%). The final visual acuity after medical or medical/surgical therapy, was no light perception (NLP) in 19 patients (33.33%), light perception (LP) to hand movements (HM) in 18 patients (31.57%), 20/400 to 20/200 in 1 patient (1.75%), 20/150 to 20/60 in 5 patients (8.77%), and 20/40 to 20/20 in 14 patients (24.56%). Four patients were lost to follow-up.
CONCLUSIONS: Fusarium is the most common cause of fungal keratitis in Mexico. Most cases (43/54, 79.6%) improved with topical antifungal therapy (either monotherapy or combined). We suggest surgical therapy with conjunctival flap or penetrating keratoplasty in advanced cases, when there has been poor response to medical therapy or a very low final visual acuity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19512910     DOI: 10.1097/ICO.0b013e31819bc2ea

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  10 in total

Review 1.  The role of cytokines and pathogen recognition molecules in fungal keratitis - Insights from human disease and animal models.

Authors:  Sixto M Leal; Eric Pearlman
Journal:  Cytokine       Date:  2012-01-26       Impact factor: 3.861

2.  Fungal antioxidant pathways promote survival against neutrophils during infection.

Authors:  Sixto M Leal; Chairut Vareechon; Susan Cowden; Brian A Cobb; Jean-Paul Latgé; Michelle Momany; Eric Pearlman
Journal:  J Clin Invest       Date:  2012-06-18       Impact factor: 14.808

3.  Fusarium keratitis at a tertiary eye care centre in India.

Authors:  Sujata Das; Savitri Sharma; Samir Mahapatra; Srikant K Sahu
Journal:  Int Ophthalmol       Date:  2014-06-15       Impact factor: 2.031

Review 4.  Role of host-defence peptides in eye diseases.

Authors:  Satya S Kolar; Alison M McDermott
Journal:  Cell Mol Life Sci       Date:  2011-05-17       Impact factor: 9.261

5.  [A 25-year-old patient with corneal infiltration].

Authors:  K Aperlic; H-J Tietz; M Erhard; T Regnath
Journal:  Ophthalmologe       Date:  2011-05       Impact factor: 1.059

6.  Current Thoughts in Fungal Keratitis: Diagnosis and Treatment.

Authors:  Zubair Ansari; Darlene Miller; Anat Galor
Journal:  Curr Fungal Infect Rep       Date:  2013-09-01

7.  Distinct roles for Dectin-1 and TLR4 in the pathogenesis of Aspergillus fumigatus keratitis.

Authors:  Sixto M Leal; Susan Cowden; Yen-Cheng Hsia; Mahmoud A Ghannoum; Michelle Momany; Eric Pearlman
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

8.  Fusarium keratitis: genotyping, in vitro susceptibility and clinical outcomes.

Authors:  Rafael A Oechsler; Michael R Feilmeier; Darlene Miller; Wei Shi; Ana Luisa Hofling-Lima; Eduardo C Alfonso
Journal:  Cornea       Date:  2013-05       Impact factor: 2.651

9.  Clinical and Mycological Features of Fungal Keratitis: A Retrospective Single-Center Study (2012-2018)

Authors:  İbrahim İnan Harbiyeli; Elif Erdem; Nuhkan Görkemli; Astan İbayev; Hazal Kandemir; Arbil Açıkalın; Macit İlkit; Meltem Yağmur
Journal:  Turk J Ophthalmol       Date:  2022-04-28

10.  The role of Syk signaling in antifungal innate immunity of human corneal epithelial cells.

Authors:  Ying Liu; Guiqiu Zhao; Jing Lin; Cui Li; Qing Li; Chengye Che; Qian Wang; Liting Hu
Journal:  BMC Ophthalmol       Date:  2015-06-03       Impact factor: 2.209

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.